Effect of Quality Improvement Tools in Congestive Heart Failure (CHF)

Congestive Heart Failure Clinical Trial

Official title:

Decreased Readmissions and Improved Quality of Care With Use of Inexpensive Checklist in Heart Failure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01446536
• Other study ID #: 11-09-02
• Status: Completed
• Phase: N/A
• First received: September 30, 2011
• Last updated: March 18, 2012
• Start date: August 2008
• Est. completion date: June 2010

Study information

• Verified date: March 2012
• Source: St. Joseph Mercy Oakland Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Hypothesis: Quality Improvement tools like "Heart Failure Discharge Checklist" which emphasizes on proper education to patients, ensure appropriate dose titration and counselling improve outcome in congestive heart failure (CHF).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 96
• Est. completion date: June 2010
• Est. primary completion date: June 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients admitted to SJMO with principal diagnosis of acute decompensated heart failure

Exclusion Criteria:

• Age less than 18 years

• Pregnant women

Study Design

Masking: Single Blind (Investigator)

Related Conditions & MeSH terms

• Congestive Heart Failure
• Heart Failure

Intervention

Other:
• Checklist cohort
CHF discharge checklist was used arbitrarily by their treating physicians in addition to the standard therapy

Locations

Country	Name	City	State
United States	St. Joseph Mercy Oakland Hospital	Pontiac	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
St. Joseph Mercy Oakland Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Readmissions	Readmission to the hospital for CHF within 6 months of discharge	6 months	No
Primary	Dose titration	up titration of medications including Beta blocer, ACE inhibitor or ARB was assessed during the hospital stay	patients were followed during the time of hospital stay, average of 5 days	No
Secondary	Medications prescribed	during the hospital stay and at discharge this outcome is measured/assessed	patients were followed during their hospital stay from admission to discharge, on an average of 5 days	No